GlassScriptPhysician profile
Bingzhong Chen
NPI 1306058292
$12,410.25
in general payments reported to CMS, 2019-2025
54 companies · $2,083 in 2025
The $2,083 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,327 · 2020: $2,963 · 2021: $1,714 · 2022: $1,154 · 2023: $413 · 2024: $755 · 2025: $2,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,613 · Travel and Lodging: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,613.00 |
| Travel and Lodging | $638.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $1,261.25 | 2019-2021 | |
| Abbvie INC. | $1,115.20 | 2019-2025 | Botox, Qulipta, Ubrelvy |
| Abbott Laboratories | $961.07 | 2022-2025 | Infinity, Proclaim |
| Novartis Pharmaceuticals Corporation | $895.66 | 2019-2025 | |
| Ucb, INC. | $648.61 | 2019-2025 | Rystiggo |
| Biogen, INC. | $588.74 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $435.22 | 2019-2022 | |
| Amgen INC. | $427.20 | 2019-2022 | |
| Sk Life Science, INC. | $404.12 | 2020-2025 | |
| Emd Serono, INC. | $394.81 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $363.47 | 2019-2025 | Austedo Xr, Ajovy |
| Allergan, INC. | $337.18 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $334.33 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $294.44 | 2019-2025 | Crexont |
| Acadia Pharmaceuticals INC | $292.51 | 2019-2024 | Nuplazid |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bingzhong Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.